Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding Study of Evocalcet (KHK7580) in Hemodialysis Patients with Secondary Hyperparathyroidism
NCT02216656Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Jul 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP7991 in secondary hyperparathyroidism (SHPT), sponsored by Kyowa Kirin. Started Jul 2014; status: completed.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT02216656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216656.